Viewing Study NCT00916669


Ignite Creation Date: 2025-12-24 @ 11:11 PM
Ignite Modification Date: 2026-01-02 @ 3:53 PM
Study NCT ID: NCT00916669
Status: WITHDRAWN
Last Update Posted: 2013-05-08
First Post: 2009-06-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)
Sponsor: Massachusetts General Hospital
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 08-097
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None INDUSTRY View